HTG Molecular Diagnostics Announces Certain Preliminary 2020 Unaudited Financial Results

NEXT STORY
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
PREV STORY
University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Reports Second Quarter 2017 Financial and Operational Results

Presented Preliminary Clinical Data on RX-3117 in Bladder Cancer at the American Society of ...

author_avatar
NASDAQ Market News

Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

author_avatar
NASDAQ Market News

ERYTECH Announces the Appointment of Dr. Melanie Rolli to its Board of Directors

author_avatar
NASDAQ Market News